Recuvyra

Expired

This medicine's authorisation has expired

fentanyl

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

Recuvyra : EPAR - Summary for the public

Product information

Recuvyra : EPAR - Product Information

Recuvyra : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Recuvyra
• Active substance:
  fentanyl
• International non-proprietary name (INN) or common name:
  fentanyl
• Species:
  Dogs
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

• EMA product number:
  EMEA/V/C/002239
• Marketing authorisation holder:
  Eli Lilly and Company Limited

  Eli Lilly and Company Limited; Lilly House; Priestley Road; Basingstoke; Hampshire RG24 9NL; United Kingdom

• Marketing authorisation issued:
  06/10/2011
• Expiry of marketing authorisation:
  13/10/2016
• Revision:
  4

Assessment history

Changes since initial authorisation of medicine

Recuvyra : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Recuvyra : EPAR - Public assessment report

Adopted Reference Number: EMA/399540/2011

CVMP summary of positive opinion for Recuvyra

Adopted Reference Number: EMA/CVMP/62249/2011